US drug company Pfizer has appointed CB Richard Ellis to sell its 325-acre research and development site in Kent.
Pfizer said it intended to have fully exited the site, in Sandwich, by the end of 2012. The
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
